Monopar Therapeutics Inc. (MNPR)
NASDAQ: MNPR · Real-Time Price · USD
16.96
+2.33 (15.93%)
At close: Nov 4, 2024, 4:00 PM
16.90
-0.06 (-0.35%)
After-hours: Nov 4, 2024, 5:53 PM EST

Monopar Therapeutics Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018 - 2015
Period Ending
Jun '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2018 - 2015
Selling, General & Admin
3.043.232.952.632.442.36
Upgrade
Research & Development
4.455.67.596.494.071.97
Upgrade
Operating Expenses
7.498.8310.549.136.514.32
Upgrade
Operating Income
-7.49-8.83-10.54-9.13-6.51-4.32
Upgrade
Interest & Investment Income
0.370.430.020.020.080.1
Upgrade
EBT Excluding Unusual Items
-7.12-8.4-10.52-9.1-6.43-4.22
Upgrade
Other Unusual Items
----0.12-
Upgrade
Pretax Income
-7.12-8.4-10.52-9.1-6.3-4.22
Upgrade
Net Income
-7.12-8.4-10.52-9.1-6.3-4.22
Upgrade
Net Income to Common
-7.12-8.4-10.52-9.1-6.3-4.22
Upgrade
Shares Outstanding (Basic)
333222
Upgrade
Shares Outstanding (Diluted)
333222
Upgrade
Shares Change (YoY)
19.36%8.69%1.97%13.82%17.56%0.32%
Upgrade
EPS (Basic)
-2.29-3.04-4.13-3.65-2.88-2.27
Upgrade
EPS (Diluted)
-2.29-3.04-4.13-3.65-2.88-2.27
Upgrade
Free Cash Flow
-6.82-7.86-7.23-7.32-4.66-3.02
Upgrade
Free Cash Flow Per Share
-2.19-2.84-2.84-2.93-2.13-1.62
Upgrade
EBIT
-7.49-8.83-10.54-9.13-6.51-4.32
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.